Monthly Archives: July 2013

Report describes malignant melanoma that developed on a pigmented skin lesion within a tattoo underlying laser removal

A case report from Germany describes a young man who developed malignant melanoma on a pre-existing nevus (skin lesion known as a mole or birthmark) within a tattoo during and between the phases of laser tattoo removal, according to a report by Laura Pohl, M.D., of Laserklinik Karlsruhe, Germany, and colleagues...

Topical analgesic may provide pain-free “skin glue” repair of cuts in children

More than 50% of children who were given a topical analgesic had no pain during wound repair with "skin glue," according to the results of a randomized controlled trial reported in CMAJ (Canadian Medical Association Journal). Tissue adhesive or "skin glue" is regularly used in pediatrics to repair minor cuts but can cause pain or a burning sensation...

Medical devices lead to higher than expected numbers of pediatric pressure ulcers

A new study has uncovered a problem in pediatrics thought to be a major issue only in adult medicine: pressure ulcers. Researchers from Cincinnati Children's Hospital Medical Center report a higher number than expected of pressure ulcers in children, and they cite an unexpected cause: medical devices...

New links between diet and acne

A review carried out by the University of Hull has shed new light on the relationship between acne and diet. Published in Dermatological Nursing, the comprehensive review assesses the latest evidence and findings about the effects of food and nutrition on acne and suggest that high glycemic index foods and milk could exacerbate the skin condition...

Strong Extension Trial Results For Innovative AC-1 BioPhotonic Platform For The Treatment Of Moderate To Severe Acne Vulgaris

KLOX Technologies Inc. ("KLOX" or the "Company") released results from its most recent extension trial in Europe for its innovative AC-1 BioPhotonic platform for the treatment of moderate to severe acne vulgaris. Of the 140 million people worldwide who suffer from this chronic and often debilitating dermatological condition, over 20% suffer from moderate to severe forms...